Abiopharma

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Smith+Nephew PLC Notification

Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action

PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation With the Schall Law Firm

Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031

ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm

Notice of change of interests of substantial holder

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

uniQURE N.V. Investigation: Investors Encouraged to Contact Kirby McInerney LLP

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference